| (210) | Number of the EPO application | 20800121 |
| (220) | Filing date of the EPO application | 2020.10.30 |
| (80) | EPO patent specification publication (B) | EPB nr. 48/2025, 2025.11.26 |
| (110) | EPO patent number | 4051710 |
| (11) | Number of the document | MD 4051710 T2 |
| (21) | Number of the application | e 2022 0968 |
| (71) | Name(s) of applicant(s), code of the country | INCYTE CORPORATION, US; |
| (72) | Name(s) of inventor(s), code of the country | ENDELL Jan, DE;
BOXHAMMER Rainer, DE;
PRETSCHER Dominik, DE; |
| (73) | Name(s) of owner(s), code of the country | INCYTE CORPORATION, US; |
| (54) | Title of the invention | Anti-tumor combination therapy comprising anti-cd19 antibody and gamma delta t-cells |
| (13) | Kind-of-document code | T2 |
| (51) | International Patent Classification | C07K 16/28 (2006.01.01); A61K 35/17 (2025.01.01); A61K 39/395 (2006.01.01); A61P 35/02 (2006.01.01); A61K 39/00 (2006.01.01) |
| (52) | Cooperative Patent Classification | C07K 16/2803 (EP); A61K 39/395 (EP); A61K 40/11 (EP); A61K 40/32 (EP); A61K 40/42 (EP); A61P 35/02 (EP); A61K 2039/505 (EP); A61K 2239/48 (EP); C07K 2317/732 (EP) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2022.09.30 |
| (49) | Date of publication of the translation of the validated European patent specification | 2026.04.30 |
| (30) | Priority | 19206479, 2019.10.31, EP |
| (74) | Patent attorney | (Procedură) CORCODEL Angela, Bd. Ştefan cel Mare nr. 134, Chişinău, Republica Moldova |
| (86) | International application | PCT/EP2020/080494, 2020.10.30 |
| (87) | International publication | WO 2021/084063, 2021.05.06 |